Warning labels on menopause treatments 'scare women', doctors tell FDA
Summary
A group of doctors, including JoAnn Pinkerton, has urged the FDA to remove strong warning labels on low-dose estrogen treatments for menopause. They argue that these warnings scare women away from using treatments that could help with menopause symptoms like dryness and discomfort.Key Facts
- Doctors, including expert JoAnn Pinkerton, asked the FDA to remove warning labels from low-dose estrogen treatments for menopause.
- These treatments help reduce symptoms like vaginal dryness and pain during sex.
- Low-dose estrogen is given locally, meaning it affects only certain body areas, unlike other hormone therapies that affect the whole body.
- The FDA's black box warning is the strongest caution on a medication label, often indicating significant risks.
- Many in the medical community now believe past studies overstated the cancer risks related to hormone therapy.
- Recent research suggests the cancer risk of these hormone treatments is low, and they offer benefits for menopausal women.
- Dr. Marty Makary, the current FDA commissioner, supports revisiting past guidelines, explaining they limited women's access to beneficial treatments.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
